Core Laboratories (NYSE:CLB – Get Free Report) updated its fourth quarter 2024 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 0.200-0.250 for the period, compared to the consensus estimate of 0.260. The company issued revenue guidance of $128.5 million-$135.5 million, compared to the consensus revenue estimate of $136.9 million. Core Laboratories also updated its Q4 guidance to $0.20-0.25 EPS.
Wall Street Analyst Weigh In
A number of research firms have recently issued reports on CLB. Stifel Nicolaus raised their price objective on shares of Core Laboratories from $18.00 to $22.00 and gave the company a “hold” rating in a research report on Friday, July 26th. Bank of America decreased their price target on Core Laboratories from $16.00 to $15.00 and set an “underperform” rating on the stock in a research note on Monday, July 15th. Piper Sandler cut their price objective on Core Laboratories from $18.00 to $17.00 and set a “neutral” rating for the company in a research report on Monday, July 15th. Finally, StockNews.com lowered shares of Core Laboratories from a “hold” rating to a “sell” rating in a research report on Tuesday, September 17th. Two analysts have rated the stock with a sell rating and two have given a hold rating to the stock. Based on data from MarketBeat.com, Core Laboratories presently has an average rating of “Hold” and an average price target of $18.00.
Read Our Latest Stock Analysis on Core Laboratories
Core Laboratories Trading Up 2.7 %
Core Laboratories (NYSE:CLB – Get Free Report) last released its quarterly earnings data on Wednesday, October 23rd. The oil and gas company reported $0.25 earnings per share for the quarter, beating the consensus estimate of $0.21 by $0.04. The business had revenue of $134.40 million for the quarter, compared to analyst estimates of $134.16 million. Core Laboratories had a return on equity of 15.20% and a net margin of 5.44%. The company’s revenue was up 7.2% compared to the same quarter last year. During the same period in the previous year, the company posted $0.22 EPS. On average, research analysts anticipate that Core Laboratories will post 0.8 earnings per share for the current fiscal year.
Core Laboratories Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Monday, November 25th. Shareholders of record on Monday, November 4th will be issued a $0.01 dividend. The ex-dividend date is Monday, November 4th. This represents a $0.04 dividend on an annualized basis and a yield of 0.21%. Core Laboratories’s dividend payout ratio is currently 4.55%.
About Core Laboratories
Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.
Recommended Stories
- Five stocks we like better than Core Laboratories
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Texas Roadhouse Stock Steering for New Highs This Year
- What is a Bond Market Holiday? How to Invest and Trade
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- What is the Nasdaq? Complete Overview with History
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.